Latest B-cell chronic lymphocytic leukemia Stories
Would Become First EMA-approved Therapy for Patients in Europe SUNNYVALE, Calif., May 22, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
IMBRUVICA Combination Data in Chronic Lymphocytic Leukemia to be Featured in Official ASCO Press Program SUNNYVALE, Calif., May 13, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
- Note: This release corresponds to ASCO abstracts LBA8512, 8587, 8590, TPS8609, TPS8608, LBA7005, 7012, TPS8599, TPS8601, 7024, TPS7095, TPS7096, 5005, 5047, 5053, 5014, 5028, TPS5071, TPS5084, 10503,
-- AbbVie plans to submit regulatory applications for venetoclax to the U.S.
SUNNYVALE, Calif., May 1, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
- Note: This press release corresponds to abstract 396 PHILADELPHIA, April 20, 2015 /PRNewswire/ -- Ibrutinib (IMBRUVICA(®)) data presented yesterday by Pharmacyclics, Inc.
Oral Presentation at the American Association of Cancer Research Annual Meeting PHILADELPHIA, April 20, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
SUNNYVALE, Calif., April 1, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
Pre-clinical data to be presented in solid tumor and blood cancer models SUNNYVALE, Calif., March 19, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
Independent Data Monitoring Committee determines HELIOS study meets its primary endpoint of progression-free survival in patients with previously treated chronic lymphocytic leukemia/small lymphocytic
- A young chicken: also used as a pet name for children.